U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...

Regulatory T cells suppress inflammation and are defective in autoimmune diseases. A recent study provides new insight into how these cells become dysregulated in multiple sclerosis and points to a ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies.

Multiple sclerosis, an autoimmune disorder, is known to be driven by 'helper' T cells, white blood cells that mount an inflammatory attack on the brain and spinal cord. A new study pinpoints the ...

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

The University of Cincinnati joins a Phase 1 clinical trial testing CAR-T cell therapy for MS, exploring this cancer ...

T cells are the immune system’s frontline fighters. When they detect danger, they rapidly multiply and transform into ...

But when you have MS, B cells recruit T cells into your brain. There, they cause inflammation. When your number of B cells goes down, your amount of T cells that cause inflammation goes down, too.

They also activate T cells that attack myelin. That contributes to MS symptoms. But B-cell therapy helps change how B cells behave. That can ease MS symptoms and slow the progression of the condition.

The cancer therapy known as CAR-T has revolutionized treatment of some blood cancers since it was introduced in 2017. The therapy uses genetically altered immune cells to home in on cancer cells ...